Discontinuation report HELIXATE FS
| Report ID | 47647 |
| Drug Identification Number | 02308592 |
| Brand name | HELIXATE FS |
| Common or Proper name | Hemophilic factor |
| Company Name | BAYER HEALTHCARE LLC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ANTIHEMOPHILIC FACTOR |
| Strength(s) | 2000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 5.0 mL |
| ATC code | B02BD |
| ATC description | VITAMIN K AND OTHER HEMOSTATICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2018-04-05 |
| Remaining supply date | 2017-04-03 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BAYER BOULEVARD WHIPPANY, NEW JERSEY UNITED STATES 07981 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-05-01 | English | Compare |
| v2 | 2018-05-03 | English | Compare |
| v3 | 2018-05-03 | French | Compare |
Showing 1 to 3 of 3